[
    [
        {
            "time": "",
            "original_text": "金斯瑞蓬勃生物牵手艾博生物、沃森生物 加速新冠疫苗商业化进程",
            "features": {
                "keywords": [
                    "金斯瑞蓬勃生物",
                    "艾博生物",
                    "沃森生物",
                    "新冠疫苗",
                    "商业化"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "金斯瑞蓬勃生物牵手艾博生物、沃森生物 加速新冠疫苗商业化进程",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "国泰君安：新冠疫苗进入业绩兑现期，港股部分标的将受益",
            "features": {
                "keywords": [
                    "国泰君安",
                    "新冠疫苗",
                    "业绩兑现",
                    "港股"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药",
                    "港股市场"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "国泰君安：新冠疫苗进入业绩兑现期，港股部分标的将受益",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]